Ankur Gupta-Wright
Overview
Explore the profile of Ankur Gupta-Wright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfurtscheller T, Tsutsunava A, Maghradze N, Gujabidze M, Bablishvili N, Yerlikaya S, et al.
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf022.
PMID: 39906319
Background: Xpert MTB/XDR (Cepheid) is recommended by the World Health Organization for drug susceptibility testing in patients with tuberculosis, with potential for rapid detection of isoniazid and fluoroquinolone resistance. However,...
2.
Crowder R, Thangakunam B, Andama A, Christopher D, Dalay V, Nwamba W, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39509711
Background: Accessible, accurate screening tests are necessary to advance tuberculosis (TB) case finding and early detection in high-burden countries. Methods: We prospectively screened adults with ≥2 weeks of cough at...
3.
Gupta-Wright A, Denkinger C
Indian J Med Res
. 2024 Oct;
159(5):391-394.
PMID: 39382418
No abstract available.
4.
Crowder R, Thangakunam B, Andama A, Christopher D, Dalay V, Dube-Nwamba W, et al.
medRxiv
. 2024 Jul;
PMID: 38947093
Background: Accessible, accurate screening tests are necessary to advance tuberculosis (TB) case finding and early detection in high-burden countries. We compared the diagnostic accuracy of available TB triage tests. Methods:...
5.
Broger T, Marx F, Theron G, Marais B, Nicol M, Kerkhoff A, et al.
Lancet Glob Health
. 2024 Jun;
12(7):e1184-e1191.
PMID: 38876764
Better access to tuberculosis testing is a key priority for fighting tuberculosis, the leading cause of infectious disease deaths in people. Despite the roll-out of molecular WHO-recommended rapid diagnostics to...
6.
Burke R, Nyirenda S, Mtenga T, Twabi H, Joekes E, Walker N, et al.
Clin Infect Dis
. 2024 May;
PMID: 38748183
Background: People with HIV (PHIV) admitted to hospital have high mortality, with tuberculosis (TB) being the major cause of death. Systematic use of new TB diagnostics could improve TB diagnosis...
7.
Gupta-Wright A, Ha H, Abdulgadar S, Crowder R, Emmanuel J, Mukwatamundu J, et al.
Lancet Glob Health
. 2024 Jan;
12(2):e226-e234.
PMID: 38245113
Background: Non-sputum-based triage tests for tuberculosis are a priority for ending tuberculosis. We aimed to evaluate the diagnostic accuracy of the late-prototype Xpert MTB Host Response (Xpert HR) blood-based assay....
8.
MacLean E, Zimmer A, den Boon S, Gupta-Wright A, Cirillo D, Cobelens F, et al.
Clin Microbiol Infect
. 2024 Jan;
30(4):481-488.
PMID: 38182047
Scope: The current tools for tuberculosis (TB) treatment monitoring, smear microscopy and culture, cannot accurately predict poor treatment outcomes. Research into new TB treatment monitoring tools (TMTs) is growing, but...
9.
Yerlikaya S, Broger T, Isaacs C, Bell D, Holtgrewe L, Gupta-Wright A, et al.
Infection
. 2023 Nov;
52(1):29-42.
PMID: 38032537
The COVID-19 pandemic brought diagnostics into the spotlight in an unprecedented way not only for case management but also for population health, surveillance, and monitoring. The industry saw notable levels...
10.
Gupta-Wright A, den Boon S, MacLean E, Cirillo D, Cobelens F, Gillespie S, et al.
Bull World Health Organ
. 2023 Nov;
101(11):730-737.
PMID: 37961060
The World Health Organization has developed target product profiles containing minimum and optimum targets for key characteristics for tests for tuberculosis treatment monitoring and optimization. Tuberculosis treatment optimization refers to...